glp 1 moa GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 and Anesthesia: Considerations and

2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity

doi: 10.1016/j.neuroscience.2011.02.023

After 68 weeks on semaglutide, patients had lost an average of over 15% of their body weight

Balance Blood Sugar & Control Appetite: Meglutide is a GLP-1 receptor agonist that mimics the bodys natural GLP-1 hormone, playing a crucial role in regulating blood sugar, suppressing appetite, and enhancing metabolism